APMD
Common StockApnimed, Inc.
Reported Shares
942.2K
Position Mix
No options reported
Reported Value
$20.6M
Portfolio Weight
13.12%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$157.4M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
APMD
Common StockApnimed, Inc.
Reported Shares
942.2K
Position Mix
No options reported
Reported Value
$20.6M
Portfolio Weight
13.12%
CTNM
Common StockContineum Therapeutics, Inc.
Reported Shares
689.6K
Position Mix
No options reported
Reported Value
$9.3M
Portfolio Weight
5.88%
SI
Common StockSHOULDER INNOVATIONS, INC.
Reported Shares
430.4K
Position Mix
No options reported
Reported Value
$8.1M
Portfolio Weight
5.17%
LLY
Common StockELI LILLY & Co
Reported Shares
6.7K
Position Mix
No options reported
Reported Value
$7.7M
Portfolio Weight
4.90%
JNJ
Common StockJOHNSON & JOHNSON
Reported Shares
22.8K
Position Mix
No options reported
Reported Value
$6.0M
Portfolio Weight
3.83%
VRTX
Common StockVERTEX PHARMACEUTICALS INC / MA
Reported Shares
7.5K
Position Mix
No options reported
Reported Value
$3.9M
Portfolio Weight
2.50%
GILD
Common StockGILEAD SCIENCES, INC.
Reported Shares
24.7K
Position Mix
No options reported
Reported Value
$3.7M
Portfolio Weight
2.33%
AMGN
Common StockAMGEN INC
Reported Shares
7.9K
Position Mix
No options reported
Reported Value
$3.3M
Portfolio Weight
2.11%
ABBV
Common StockAbbVie Inc.
Reported Shares
12.3K
Position Mix
No options reported
Reported Value
$3.2M
Portfolio Weight
2.04%
DXCM
Common StockDEXCOM INC
Reported Shares
37.2K
Position Mix
No options reported
Reported Value
$3.2M
Portfolio Weight
2.04%
SMMT
Common StockSummit Therapeutics Inc.
Reported Shares
177.2K
Position Mix
No options reported
Reported Value
$3.0M
Portfolio Weight
1.90%
RCUS
Common StockArcus Biosciences, Inc.
Reported Shares
115.9K
Position Mix
No options reported
Reported Value
$3.0M
Portfolio Weight
1.90%
MRK
Common StockMerck & Co., Inc.
Reported Shares
20.5K
Position Mix
No options reported
Reported Value
$3.0M
Portfolio Weight
1.90%
BNTX
Depositary ReceiptBioNTech SE
Reported Shares
30.2K
Position Mix
No options reported
Reported Value
$3.0M
Portfolio Weight
1.89%
ORKA
Common StockOruka Therapeutics, Inc.
Reported Shares
35.3K
Position Mix
No options reported
Reported Value
$2.9M
Portfolio Weight
1.87%
AVTX
Common StockAvalo Therapeutics, Inc.
Reported Shares
177.3K
Position Mix
No options reported
Reported Value
$2.7M
Portfolio Weight
1.73%
INSM
Common StockINSMED Inc
Reported Shares
23.7K
Position Mix
No options reported
Reported Value
$2.7M
Portfolio Weight
1.72%
AVBP
Common StockArriVent BioPharma, Inc.
Reported Shares
87.3K
Position Mix
No options reported
Reported Value
$2.6M
Portfolio Weight
1.68%
TNGX
Common StockTango Therapeutics, Inc.
Reported Shares
105.8K
Position Mix
No options reported
Reported Value
$2.6M
Portfolio Weight
1.68%
ARGX
Depositary ReceiptARGENX SE
Reported Shares
2.7K
Position Mix
No options reported
Reported Value
$2.6M
Portfolio Weight
1.63%